The Ontario Tumour Bank (OTB) provides cancer researchers with a diverse selection of high-quality biospecimens and derivatives, comprehensively annotated with de-identified clinical data. Biospecimens are the key to the development and testing of next-generation diagnostics and treatments. Since 2004, OTB has been making this this type of research possible by collecting and dispensing the biospecimens needed for high-impact studies.

Operating at state-of-the-art hospitals and cancer centres across Ontario, OTB is made possible through collaboration. Working with local pathologists, medical oncologists, surgeons and other hospital personnel, specially trained staff members obtain patient consent, collect tissues and assemble comprehensive clinical information about each donor and the corresponding biospecimens. A unique governance model ensures that OTB meets the highest scientific and ethical standards.

The high-quality biospecimens, derivatives and clinical data are an important resource for scientists engaged in translational research who are developing better diagnostic tools and new drug therapies. Researchers can depend on OTB to provide products and services of high quality, diversity, and integrity.

OTB is a program of the Ontario Institute for Cancer Research (OICR). Funded by the Government of Ontario, OICR is a not-for-profit organization that supports research on the prevention, early detection, diagnosis, treatment and control of cancer.